Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Sep:508:213-216.
doi: 10.1016/j.cca.2020.05.041. Epub 2020 May 23.

An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19

Affiliations

An evidence for correlation between the glutathione S-transferase T1 (GSTT1) polymorphism and outcome of COVID-19

Mostafa Saadat. Clin Chim Acta. 2020 Sep.
No abstract available

Keywords: COVID-19; GSTM1; GSTT1; Polymorphism.

PubMed Disclaimer

Conflict of interest statement

Declaration of Competing Interest The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
Normal P-P plot of regression standardized residual. Dependent variable is log-transformed of mortality, explanatory variables are the life expectancy at birth and frequency of the null genotypes of GSTT1. “Sensitivity analysis” was performed after Australia, USA, and Canada, South Korea and China were removed from the data set.

Comment in

References

    1. Bolt H.M., Thier R. Relevance of the deletion polymorphisms of the glutathione S-transferases GSTT1 and GSTM1 in pharmacology and toxicology. Curr Drug Metab. 2006;7:613–628. - PubMed
    1. Khomich O., Kochetkov S., Bartosch B., Ivanov A.V. Redox biology of respiratory viral infections. Viruses. 2018;10:392. - PMC - PubMed
    1. Henry B.M., Vikse J., Benoit S., Favaloro E.J., Lippi G. Hyperinflammation and derangement of renin-angiotensin-aldosterone system in COVID-19: A novel hypothesis for clinically suspected hypercoagulopathy and microvascular immunothrombosis. Clin Chim Acta. 2020;507:167–173. - PMC - PubMed
    1. Shneider A., Kudriavtsev A., Vakhrusheva A. Can melatonin reduce the severity of COVID-19 pandemic? Int Rev Immunol. 2020;29:1–10. - PubMed
    1. Zhang R., Wang X., Ni L., Di X., Ma B., Niu S., Liu C., Reiter R.J. COVID-19: Melatonin as a potential adjuvant treatment. Life Sci. 2020;250:117583. - PMC - PubMed

MeSH terms